Expression of hygromycin phosphotransferase alters virulence of Histoplasma capsulatum

被引:13
|
作者
Smulian, A. George
Gibbons, Reta S.
Demland, Jeffery A.
Spaulding, Deborah T.
Deepe, George S., Jr.
机构
[1] Univ Cincinnati, Coll Med, Div Infect Dis, Cincinnati, OH USA
[2] Cincinnati VA Med Ctr, Cincinnati, OH USA
关键词
D O I
10.1128/EC.00139-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Escherichia coli hygromycin phosphotransferase (hph) gene, which confers hygromycin resistance, is commonly used as a dominant selectable marker in genetically modified bacteria, fungi, plants, insects, and mammalian cells. Expression of the hph gene has rarely been reported to induce effects other than those expected. Hygromycin B is the most common dominant selectable marker used in the molecular manipulation of Histoplasma capsulatum in the generation of knockout strains of H. capsulatum or as a marker in mutant strains. hph-expressing organisms appear to have no defect in long-term in vitro growth and survival and have been successfully used to exploit host-parasite interaction in short-term cell culture systems and animal experiments. We introduced the hph gene as a selectable marker together with the gene encoding green fluorescent protein into wild-type strains of H. capsulatum. Infection of mice with hph-expressing H. capsulatum yeast cells at sublethal doses resulted in lethality. The lethality was not attributable to the site of integration of the hph construct into the genomes or to the method of integration and was not H. capsulatum strain related. Death of mice was not caused by altered cytokine profiles or an overwhelming fungal burden. The lethality was dependent on the kinase activity of hygromycin phosphotransferase. These results should raise awareness of the potential detrimental effects of the hph gene.
引用
收藏
页码:2066 / 2071
页数:6
相关论文
共 50 条
  • [21] HISTOPLASMA CAPSULATUM IN THE EYE
    SCHOLZ, R
    GREEN, WR
    KUTYS, R
    SUTHERLAND, J
    RICHARDS, RD
    OPHTHALMOLOGY, 1984, 91 (09) : 1100 - 1104
  • [22] HISTOPLASMA CAPSULATUM ENDOCARDITIS
    BLAIR, TP
    WAUGH, RA
    POLLACK, M
    ASHWORTH, HE
    YOUNG, NA
    ANDERSON, SE
    BEM, TP
    AMERICAN HEART JOURNAL, 1980, 99 (06) : 783 - 788
  • [23] HISTOPLASMA CAPSULATUM ENDOCARDITIS
    BLAIR, T
    CHEST, 1981, 79 (06) : 620 - 620
  • [24] VARIABLE EXPRESSION OF A YEAST-PHASE-SPECIFIC GENE IN HISTOPLASMA-CAPSULATUM STRAINS DIFFERING IN THERMOTOLERANCE AND VIRULENCE
    KEATH, EJ
    PAINTER, AA
    KOBAYASHI, GS
    MEDOFF, G
    INFECTION AND IMMUNITY, 1989, 57 (05) : 1384 - 1390
  • [25] HISTOPLASMA CAPSULATUM EPIDIDYMITIS
    KAUFFMAN, CA
    SLAMA, TG
    WHEAT, LJ
    JOURNAL OF UROLOGY, 1981, 125 (03) : 434 - 435
  • [26] Pathogenicity & virulence of Histoplasma capsulatum-A multifaceted organism adapted to intracellular environments
    Valdez, Alessandro F.
    Miranda, Daniel Zamith
    Guimaraes, Allan Jefferson
    Nimrichter, Leonardo
    Nosanchuk, Joshua D.
    VIRULENCE, 2022, 13 (01) : 1900 - 1919
  • [27] Histoplasma capsulatum requires peroxisomes for multiple virulence functions including siderophore biosynthesis
    Brechting, Peter J.
    Shah, Chandan
    Rakotondraibe, Liva
    Shen, Qian
    Rappleye, Chad A.
    MBIO, 2023, 14 (04): : e0328422
  • [28] Antibody Binding Alters the Characteristics and Contents of Extracellular Vesicles Released by Histoplasma capsulatum
    Baltazar, Ludmila Matos
    Nakayasu, Ernesto S.
    Sobreira, Tiago J. P.
    Choi, Hyungwon
    Casadevall, Arturo
    Nimrichter, Leonardo
    Nosanchuk, Joshua D.
    MSPHERE, 2016, 1 (02):
  • [29] An aberrant variant of Histoplasma capsulatum var capsulatum
    Sutton, DA
    Padhye, AA
    Standard, PG
    Rinaldi, MG
    JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (03) : 734 - 735
  • [30] Histoplasma capsulatum var. capsulatum Darling
    Cruz, Rodrigo
    REVISTA CHILENA DE INFECTOLOGIA, 2013, 30 (03): : 311 - 312